Analysis and Perspectives

Apr 14, 2023

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.

Apr 14, 2023

DelveInsight has analyzed some of the key abstracts and top data readouts from the American Association for Cancer Research (AACR) 2023. Several pharma and biotech companies

Apr 12, 2023

Polymerase Chain Reaction Market is evolving at an immense pace. Several companies are working in the domain. Major trends and developments

Apr 07, 2023

The pipeline is very robust as over 75 leading companies are developing novel therapies for plaque psoriasis treatment.

Apr 05, 2023

The Drug Delivery Devices Market is evolving at an immense pace owing to ongoing developments in the domain. Several major companies are developing new devices

Apr 03, 2023

DAYBUE (trofinetide) by Acadia Pharmaceuticals & Neuren Pharmaceuticals became the first & only FDA-approved drug for Rett syndrome treatment.

Mar 31, 2023

Cell therapies open doors for advanced peripheral artery disease treatment and are discussed comprehensively as novel regenerative medicine.

Mar 29, 2023

In recent years, Probiotics and prebiotics products have gained intense development and attention from the scientific, researchers, and healthcare giants due to their beneficial roles in maintaining human health. Several clinical studies have demonstrated a positive effect of probiotics on gastrointestinal diseases...

Mar 27, 2023

SHTG and FCS treatment market to evolve with the launch of ApoC-III inhibiting drugs, Olezarsen (Ionis) and ARO-APOC3 (Arrowhead). Clinical…

Mar 24, 2023

With increasing MedTech companies, their products, & regulatory approvals, we can see increased adoption of robotics in surgery.